We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · January 23, 2023

Clinical Outcomes in Patients With De Novo Metastatic HER2-Low vs HER2-Zero Breast Cancer

NPJ breast cancer


Additional Info

Disclosure statements are available on the authors' profiles:

NPJ breast cancer
Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis
NPJ Breast Cancer 2022 Dec 30;8(1)135, C Jiang, S Perimbeti, L Deng, CL Shapiro, S Gandhi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading